The present invention discloses a polymerized high-molecular-weight sterically hindered amine having a general formula I, the sterically hindered amine has the advantages of high molecular weight, difficult migration in polymer products, good thermal stability, etc., and can stabilize and/or be flame retardant to organic substances sensitive to light, heat or oxidation, and furthermore, can be made to have better compatibility with different types of polymer materials by changing substituents.

##STR00001##

Polyethylene glycol (PEG)-b-poly(β-amino ester) (PBAE) co-polymers (PEG-PBAE) and blends of PEG-PBAEs and PBAEs and their use for delivering drugs, genes, and other pharmaceutical or therapeutic agents safely and effectively to different sites in the body and to different cells, such as cancer cells, are disclosed.

The invention relates to cleaning compositions comprising polyalkanolamine polymers. The present invention further relates to methods of cleaning dishware and hard surfaces using such cleaning compositions.

The present invention relates to aqueous binder compositions comprising an aqueous polymer latex of a film forming carboxylated polymer and a branched polyetheramine polyol dissolved in the aqueous phase of the aqueous polymer latex, wherein essentially all of the amino groups in the branched polyetheramine polyol are tertiary amine groups. The present invention also relates to water-borne coating compositions containing such an aqueous binder composition.

The present disclosure provides branched poly(β-amino esters) (PBAEs) of Formula (I) made by reacting primary amines with diacrylates. Further provided herein are compositions comprising the polymers of Formula (I), and methods of using the compositions and polymers as described herein for the treatment of disease.

L-(R).sub.n   (I)

Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.

Use of hydrophobically modified polyalkanolamines obtainable by condensing at least one trialkanolamine and optionally further condensable monomers and reacting at least one of the terminal OH groups with suitable reactants capable of reacting with OH groups and comprising long chain hydrocarbon groups as wax inhibitor, pour point depressant and additive for lubricants.

An adduct of a polyetheramine and an epoxy-containing compound is used as an agent for reducing drying shrinkage and/or drying cracking in a mineral binder composition.

This invention relates to odor control molecules comprised of polyethyleneimine compounds containing N-halamine and derivatives thereof.

A polytriazole copolymer may include substituted phenyls, substituted benzyls, or both substituted phenyls and substituted benzyls. The substituted phenyls and the substituted benzyls may be independently substituted with hydrogen, bromo, fluoro, chloro, iodo, hydroxy, methyl, trifluoromethyl, dimethylamino, tert-butyl, carboxyl, triphenylmethyl, tris(4-fluorophenyl)methyl, tris(4-methylphenyl)methyl, (4-hydroxyphenyl)diphenylmethyl, and difluoromethoxy groups. The polytriazole copolymer may have a degree of polymerization from 25 to 250.